{"id":2604,"date":"2019-09-16T17:26:44","date_gmt":"2019-09-16T21:26:44","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/purdues-sackler-family-transferring-billions-of-dollars\/"},"modified":"2022-06-27T02:31:39","modified_gmt":"2022-06-27T06:31:39","slug":"la-famille-purdues-sackler-transfere-des-milliards-de-dollars","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/fr\/papiers-blanc\/la-famille-purdues-sackler-transfere-des-milliards-de-dollars\/","title":{"rendered":"La famille Sackler de Purdue transf\u00e8re des milliards de dollars"},"content":{"rendered":"<p>The New York Attorney General&#8217;s Office said Friday it has uncovered roughly $1 billion in wire transfers by the Sackler family, owners of Purdue Pharma, that appear to be an attempt by the family to shield part of its fortune as it defended itself against a myriad of lawsuits alleging it fueled the opioid crisis.<\/p>\n<p>New York state issued subpoenas last month to several financial institutions that Purdue does business with. Records from one financial<br \/>\ninstitution alone show that the Sacklers transferred about $1 billion through family trusts and Swiss bank accounts, according to court filings.<\/p>\n<p>The Sackler family is reportedly worth about $13 billion, and it\u2019s unclear whether Purdue\u2019s bankruptcy will shield them from liability.<\/p>","protected":false},"excerpt":{"rendered":"<p>Le bureau du procureur g\u00e9n\u00e9ral de New York a d\u00e9clar\u00e9 vendredi avoir d\u00e9couvert environ $1 milliard de virements \u00e9lectroniques par la famille Sackler, propri\u00e9taires de Purdue Pharma, qui semblent \u00eatre un\u2026<\/p>","protected":false},"featured_media":0,"menu_order":279,"template":"","whitepaper_category":[75,101,253,254],"whitepaper-source":[63],"class_list":["post-2604","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-opioids-litigation","whitepaper_category-new-york-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-law360"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/whitepapers\/2604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/whitepapers\/2604\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/media?parent=2604"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/whitepaper_category?post=2604"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/whitepaper-source?post=2604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}